[1] G.J. Braunstahl, United airways concept: what does it teach us about systemic inflammation in airways disease? Proc. Am. Thorac. Soc. 6 (8) (2009) 652–654.
[2] G. Ciprandi, D. Caimmi, M. Miraglia Del Giudice, M. La Rosa, C. Salpietro, G.L. Marseglia, Recent developments in United airways disease, Allergy Asthma Immunol Res 4 (4) (2012) 171–177.
[3] A.C.A. Yii, T.R. Tay, X.N. Choo, M.S.Y. Koh, A.K.H. Tee, D.Y. Wang, Precision medicine in united airways disease: a ""treatable traits"" approach, Allergy 73 (10) (2018) 1964–1978.
[4] A.G. Hansen, L.J. Stovner, K. Hagen, A.S. Helvik, W.M. Thorstensen, S. Nordgard, et al., Paranasal sinus opacification in headache sufferers: a population-based imaging study (the HUNT study-MRI), Cephalalgia 37 (6) (2017) 509–516.
[5] D. Jarvis, R. Newson, J. Lotvall, D. Hastan, P. Tomassen, T. Keil, et al., Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe, Allergy 67 (1) (2012) 91–98.
[6] K. Hakansson, L. Konge, S.F. Thomsen, V. Backer, C. von Buchwald, Sinonasal inflammation in COPD: a systematic review, Eur. Respir. J. 42 (5) (2013) 1402–1411.
[7] E. Handley, C.H. Nicolson, M. Hew, A.L. Lee, Prevalence and clinical implications of chronic rhinosinusitis in people with bronchiectasis: a systematic review,J Allergy Clin Immunol Pract 7 (6) (2019) 2004–2012 e1.
[8] W.J. Guan, Y.H. Gao, H.M. Li, J.J. Yuan, R.C. Chen, N.S. Zhong, Impacts of co- existing chronic rhinosinusitis on disease severity and risks of exacerbations in Chinese adults with bronchiectasis, PloS One 10 (9) (2015), e0137348.
[9] D.E. Shaw, A.R. Sousa, S.J. Fowler, L.J. Fleming, G. Roberts, J. Corfield, et al., Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort, Eur. Respir. J. 46 (5) (2015) 1308–1321.
[10] A. ten Brinke, D.C. Grootendorst, J.T. Schmidt, F.T. De Bruine, M.A. van Buchem,P.J. Sterk, et al., Chronic sinusitis in severe asthma is related to sputum eosinophilia, J. Allergy Clin. Immunol. 109 (4) (2002) 621–626.
[11] T. Nishio, K. Wakahara, Y. Suzuki, N. Nishio, S. Majima, S. Nakamura, et al., Mixed cell type in airway inflammation is the dominant phenotype in asthma patients with severe chronic rhinosinusitis, Allergol. Int. 68 (4) (2019) 515–520.
[12] S. Tanaka, T. Hirota, A. Kamijo, H. Ishii, K. Hatsushika, S. Fujieda, et al., Lung functions of Japanese patients with chronic rhinosinusitis who underwent endoscopic sinus surgery, Allergol. Int. 63 (1) (2014) 27–35.
[13] S.Y. Lee, S.H. Yoon, W.J. Song, S.H. Lee, H.R. Kang, S.S. Kim, et al., Influence of chronic sinusitis and nasal polyp on the lower airway of subjects without lower airway diseases, Allergy Asthma Immunol Res 6 (4) (2014) 310–315.
[14] A. Niimi, H. Matsumoto, R. Amitani, Y. Nakano, M. Mishima, M. Minakuchi, et al., Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices, Am. J. Respir. Crit. Care Med. 162 (4 Pt 1) (2000) 1518–1523.
[15] M. Hoshino, S. Matsuoka, H. Handa, T. Miyazawa, K. Yagihashi, Correlation between airflow limitation and airway dimensions assessed by multidetector CT in asthma, Respir. Med. 104 (6) (2010) 794–800.
[16] M. Hasegawa, Y. Nasuhara, Y. Onodera, H. Makita, K. Nagai, S. Fuke, et al., Airflow limitation and airway dimensions in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 173 (12) (2006) 1309–1315.
[17] T. Achenbach, O. Weinheimer, A. Biedermann, S. Schmitt, D. Freudenstein,E. Goutham, et al., MDCT assessment of airway wall thickness in COPD patients using a new method: correlations with pulmonary function tests, Eur. Radiol. 18(12) (2008) 2731–2738.
[18] F. Capraz, E. Kunter, H. Cermik, A. Ilvan, S. Pocan, The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics, Lung 185 (2) (2007) 89–96.
[19] S. Ishii, M. Iikura, M. Hojo, H. Sugiyama, Use of 3D-CT airway analysis software to assess a patient with severe persistent bronchial asthma treated with bronchial thermoplasty, Allergol. Int. 66 (3) (2017) 501–503.
[20] M. Zanon, D.L. Strieder, A.S. Rubin, G. Watte, E. Marchiori, P.F.G. Cardoso, et al., Use of MDCT to assess the results of bronchial thermoplasty, Am. J. Roentgenol. 209 (4) (2017) 752–756.
[21] W.J. Fokkens, V.J. Lund, J. Mullol, C. Bachert, I. Alobid, F. Baroody, et al., European position paper on rhinosinusitis and nasal polyps 2012, Rhinol Suppl. 23 (2012) 3.
[22] S.E. Kountakis, P. Arango, D. Bradley, Z.K. Wade, L. Borish, Molecular and cellular staging for the severity of chronic rhinosinusitis, Laryngoscope 114 (11) (2004) 1895–1905.
[23] N. Ashraf, N. Bhattacharyya, Determination of the ""incidental"" Lund score for the staging of chronic rhinosinusitis, Otolaryngol. Head Neck Surg. 125 (5) (2001) 483–486.
[24] P.A. de Jong, N.L. Muller, P.D. Pare, H.O. Coxson, Computed tomographic imaging of the airways: relationship to structure and function, Eur. Respir. J. 26 (1) (2005) 140–152.
[25] M. Hackx, A.A. Bankier, P.A. Gevenois, Chronic obstructive pulmonary disease: CT quantification of airways disease, Radiology 265 (1) (2012) 34–48.
[26] C. Hopkins, J.P. Browne, R. Slack, V. Lund, P. Brown, The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol. Head Neck Surg. 137 (4) (2007) 555–561.
[27] C.H. Martinez, Y.H. Chen, P.M. Westgate, L.X. Liu, S. Murray, J.L. Curtis, et al., Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease, Thorax 67 (5) (2012) 399–406.
[28] P.M. Jairam, Y. van der Graaf, J.W. Lammers, W.P. Mali, P.A. de Jong, P.S. group, Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality, Thorax 70 (8) (2015) 725–731.
[29] K. Nishimoto, M. Karayama, N. Inui, K. Mori, M. Kono, H. Hozumi, et al., Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma, Sci. Rep. 7 (1) (2017) 10187.
[30] F.A. Mohamed Hoesein, P.A. de Jong, J.W. Lammers, W.P. Mali, M. Schmidt, H.J. de Koning, et al., Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation, Eur. Respir. J. 45 (3) (2015) 644–651.
[31] E.C. Oelsner, B.M. Smith, E.A. Hoffman, R. Kalhan, K.M. Donohue, J.D. Kaufman, et al., Prognostic significance of large airway dimensions on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study, Ann Am Thorac Soc 15 (6) (2018) 718–727.
[32] J.P. Charbonnier, E. Pompe, C. Moore, S. Humphries, B. van Ginneken, B. Make, et al., Airway wall thickening on CT: relation to smoking status and severity of COPD, Respir. Med. 146 (2019) 36–41.
[33] H. Kimura, S. Konno, Y. Nakamaru, H. Makita, N. Taniguchi, K. Shimizu, et al., Sinus computed tomographic findings in adult smokers and nonsmokers with asthma. Analysis of clinical indices and biomarkers, Ann Am Thorac Soc 14 (3) (2017) 332–341.
[34] T. Tokunaga, M. Sakashita, T. Haruna, D. Asaka, S. Takeno, H. Ikeda, et al., Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study, Allergy 70 (8) (2015) 995–1003.
[35] A. Kato, Immunopathology of chronic rhinosinusitis, Allergol. Int. 64 (2) (2015)121–130.
[36] M. Okano, S. Kariya, N. Ohta, Y. Imoto, S. Fujieda, K. Nishizaki, Association and management of eosinophilic inflammation in upper and lower airways, Allergol. Int. 64 (2) (2015) 131–138.
[37] J.V. Fahy, Type 2 inflammation in asthma–present in most, absent in many, Nat. Rev. Immunol. 15 (1) (2015) 57–65.
[38] M.R. Loebinger, D. Bilton, R. Wilson, Upper airway 2: bronchiectasis, cystic fibrosis and sinusitis, Thorax 64 (12) (2009) 1096–1101.
[39] D.L. Hamilos, Chronic Rhinosinusitis in patients with cystic fibrosis, J Allergy Clin Immunol Pract 4 (4) (2016) 605–612.